
Merck Serono’s once failed lung cancer vaccine treatment Stimuvax has been given a second chance as the German firm begins …

Speciality biopharma firm Circassia has appointed Dr Francesco Granata as its non-executive chairman. Granata is executive in Residence at Warburg …



Pfizer’s worst fears have been confirmed today by NICE, which has rejected its new lung cancer drug Xalkori because of …
Zaicom International which focusses on comms, market research and regulatory solutions in healthcare has appointed Stuart Cossins as its chief …

The government has acknowledged that a GSK flu vaccine administered during the swine flu breakout could have caused children to …

The drug industry has lagged behind other sectors in adopting more efficient manufacturing, but there are signs that one key …

Pfizer has begun using digital drug representatives to market medicines, leaving the decision as to whether they want to see …

Sarah Verhoeff who joined PAN in January has been promoted to director and joins the agency’s Board. Previously business director …
Boehringer Ingelheim has signed a deal with Roche subsidiary Ventana Medical Systems to develop companion diagnostic tests for Boehringer’s oncology …


Under new plans by the British Labour Party welfare payments could be stopped in the future for parents who fail …

Pfizer has launched a first-of-its-kind project that enables patients who have participated in clinical trials the ability to download their …

An experimental treatment by GSK and Prosensa for a rare type of muscle-degenerating disease has failed to meet its primary …